Literature DB >> 14985614

Clearing the airways: advocacy and regulation for smoke-free airlines.

A L Holm1, R M Davis.   

Abstract

OBJECTIVE: To examine the advocacy and regulatory history surrounding bans on smoking in commercial airliners.
METHODS: Review of historical documents, popular press articles, and other sources to trace the timeline of events leading up to the US ban on smoking in airliners and subsequent efforts by airlines and other nations.
RESULTS: In early years, efforts by flight attendants and health advocates to make commercial airliners smoke-free were not productive. Advocacy efforts between 1969 and 1984 resulted in maintenance of the status quo, with modest exceptions (creation of smoking and non-smoking sections of aircraft, and a ban on cigar and pipe smoking). Several breakthrough events in the mid 1980s, however, led to an abrupt turnaround in regulatory efforts. The first watershed event was the publication in 1986 of the National Academy of Science's report on the airliner cabin environment, which recommended banning smoking on all commercial flights. Subsequently, following concerted lobbying efforts by health advocates, Congress passed legislation banning smoking on US domestic flights of less than two hours, which became effective in 1988. The law was made permanent and extended to flights of less than six hours in 1990. This landmark legislation propelled the adoption of similar rules internationally, both by airlines and their industry's governing bodies. Though the tobacco industry succeeded in stalling efforts to create smoke-free airways, it was ultimately unable to muster sufficient grassroots support or scientific evidence to convince the general public or policymakers that smoking should continue to be allowed on airlines.
CONCLUSIONS: The movement to ban smoking in aircraft represents a case study in effective advocacy for smoke-free workplaces. Health advocates, with crucial assistance from flight attendants, used an incremental advocacy process to push for smoking and non-smoking sections on US commercial flights, then for smoking bans on short domestic flights, and finally for completely smoke-free domestic and international flights. Through the course of the battle, advocates from all quarters of tobacco control presented a unified message, exhibited remarkable focus on an attainable goal, and effectively leveraged their relationships with champions in both government and the private sector.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985614      PMCID: PMC1766149     

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  4 in total

1.  Push or be punished: tobacco industry documents reveal aggression against businesses that discourage tobacco use.

Authors:  A Landman
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

Review 2.  Flying the smoky skies: secondhand smoke exposure of flight attendants.

Authors:  J Repace
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

3.  Passive smoking on commercial airline flights.

Authors:  M E Mattson; G Boyd; D Byar; C Brown; J F Callahan; D Corle; J W Cullen; J Greenblatt; N J Haley; K Hammond
Journal:  JAMA       Date:  1989-02-10       Impact factor: 56.272

Review 4.  A tobacco industry study of airline cabin air quality: dropping inconvenient findings.

Authors:  K Neilsen; S A Glantz
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

  4 in total
  12 in total

1.  Reducing the gap between the economic costs of tobacco and funds for tobacco training in schools of public health.

Authors:  Liza S Rovniak; Marilyn F Johnson-Kozlow; Melbourne F Hovell
Journal:  Public Health Rep       Date:  2006 Sep-Oct       Impact factor: 2.792

Review 2.  The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.

Authors:  Sungkyu Lee; Pamela M Ling; Stanton A Glantz
Journal:  Cancer Causes Control       Date:  2012-02-28       Impact factor: 2.506

Review 3.  Smoke-free airlines and the role of organized labor: a case study.

Authors:  Jocelyn Pan; Elizabeth M Barbeau; Charles Levenstein; Edith D Balbach
Journal:  Am J Public Health       Date:  2005-03       Impact factor: 9.308

Review 4.  Tobacco industry consumer research on socially acceptable cigarettes.

Authors:  P M Ling; S A Glantz
Journal:  Tob Control       Date:  2005-10       Impact factor: 7.552

5.  Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions.

Authors:  Peggy Lopipero; Lisa A Bero
Journal:  Tob Control       Date:  2006-08       Impact factor: 7.552

6.  Advocacy to support climate and health policies: recommended actions for the Society of Behavioral Medicine.

Authors:  Andrea S Mendoza-Vasconez; Elizabeth McLaughlin; James F Sallis; Edward Maibach; Elissa Epel; Gary Bennett; Leticia Nogueira; Julian Thayer; William H Dietz
Journal:  Transl Behav Med       Date:  2022-05-25       Impact factor: 3.626

7.  Associations between respiratory illnesses and secondhand smoke exposure in flight attendants: A cross-sectional analysis of the Flight Attendant Medical Research Institute Survey.

Authors:  Alexis L Beatty; Thaddeus J Haight; Rita F Redberg
Journal:  Environ Health       Date:  2011-09-24       Impact factor: 5.984

8.  What Low-income Smokers Have Learned from Public Health Pedagogy: A Narrative Inquiry.

Authors:  Susan Veldheer; Robin Redmon Wright; Jonathan Foulds
Journal:  Am J Health Behav       Date:  2019-07-01

9.  Participation and argument in legislative debate on statewide smoking restrictions.

Authors:  Dorie E Apollonio; Peggy Lopipero; Lisa A Bero
Journal:  Health Res Policy Syst       Date:  2007-10-22

10.  Clear Skies and Grey Areas: Flight Attendants' Secondhand Smoke Exposure and Attitudes toward Smoke-Free Policy 25 Years since Smoking was Banned on Airplanes.

Authors:  Frances A Stillman; Andrea Soong; Laura Y Zheng; Ana Navas-Acien
Journal:  Int J Environ Res Public Health       Date:  2015-06-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.